P-Hydroxynorephedrine

p-Hydroxynorephedrine
Clinical data
Other names4-Hydroxynorephedrine
para-Hydroxynorephedrine
Identifiers
IUPAC name
  • 4-(2-amino-1-hydroxypropyl)phenol
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC9H13NO2
Molar mass167.208 g·mol−1
3D model (JSmol)
SMILES
  • [C@@H]([C@H](C)N)(O)C1=CC=C(O)C=C1
InChI
  • InChI=1S/C9H13NO2/c1-6(10)9(12)7-2-4-8(11)5-3-7/h2-6,9,11-12H,10H2,1H3/t6-,9-/m0/s1
  • Key:JAYBQRKXEFDRER-RCOVLWMOSA-N

p-Hydroxynorephedrine (PHN or 4-hydroxynorephedrine) is the para-hydroxy analog of norephedrine and an active sympathomimetic metabolite of amphetamine in humans.[1][2] When it occurs as a metabolite of amphetamine, it is produced from both p-hydroxyamphetamine and norephedrine.[2][3][4]

Amphetamine metabolism

Metabolic pathways of amphetamine in humans[sources 1]
Graphic of several routes of amphetamine metabolism
4-Hydroxyphenylacetone
Phenylacetone
Benzoic acid
Hippuric acid
Para-
Hydroxylation
Para-
Hydroxylation
Para-
Hydroxylation
unidentified
Beta-
Hydroxylation
Beta-
Hydroxylation
Oxidative
Deamination
Oxidation
unidentified
Glycine
Conjugation
XM-ligase
GLYAT
The image above contains clickable links
In humans, para-hydroxynorephedrine is a metabolite of amphetamine. The aromatic ring hydroxylation of the substituted amphetamines in this image is mediated by CYP2D6 and dopamine β-hydroxylase.

Notes

  1. 4-Hydroxyamphetamine has been shown to be metabolized into 4-hydroxynorephedrine by dopamine beta-hydroxylase (DBH) in vitro and it is presumed to be metabolized similarly in vivo.'"`UNIQ--ref-00000032-QINU`"''"`UNIQ--ref-00000033-QINU`"' Evidence from studies that measured the effect of serum DBH concentrations on 4-hydroxyamphetamine metabolism in humans suggests that a different enzyme may mediate the conversion of 4-hydroxyamphetamine to 4-hydroxynorephedrine;'"`UNIQ--ref-00000034-QINU`"''"`UNIQ--ref-00000035-QINU`"' however, other evidence from animal studies suggests that this reaction is catalyzed by DBH in synaptic vesicles within noradrenergic neurons in the brain.'"`UNIQ--ref-00000036-QINU`"''"`UNIQ--ref-00000037-QINU`"'

See also

  • Hydroxynorephedrine

References

  1. '"`UNIQ--ref-00000029-QINU`"''"`UNIQ--ref-0000002A-QINU`"''"`UNIQ--ref-0000002B-QINU`"''"`UNIQ--ref-0000002C-QINU`"''"`UNIQ--ref-0000002D-QINU`"''"`UNIQ--ref-0000002E-QINU`"''"`UNIQ--ref-0000002F-QINU`"''"`UNIQ--ref-00000030-QINU`"'

References

  1. "p-Hydroxynorephedrine". NCBI. PubChem Compound. Retrieved 25 October 2013.
  2. 1 2 "Adderall XR Prescribing Information" (PDF). Medication Guide. United States Food and Drug Administration. Retrieved 7 October 2013.
  3. "Amphetamine: Biomedical Effects and Toxicity". NCBI. Pubchem Compound. Retrieved 12 October 2013.
  4. Santagati NA, Ferrara G, Marrazzo A, Ronsisvalle G (September 2002). "Simultaneous determination of amphetamine and one of its metabolites by HPLC with electrochemical detection". J. Pharm. Biomed. Anal. 30 (2): 247–55. doi:10.1016/S0731-7085(02)00330-8. PMID 12191709.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.